Rezan Koçak Ulucaköy, “Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?”, Archives of Rheumatology, vol. 39, no. 3, pp. 368–374, Sep. 2024.